title: Comparing the roles of antibodies to nontyphoidal Salmonella enterica in high- and low-income countries and implications for vaccine development.
authors.affiliation: Novartis Vaccines Institute for Global Health, Siena, Italy.
authors.forename: Calman A
authors.initials: CA
authors.lastname: MacLennan
authors.forename: Sharon M
authors.initials: SM
authors.lastname: Tennant
mesh_terms: D001770:Blood Bactericidal Activity; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology*; D008297:Male; D012480:Salmonella Infections / Q000276:immunology*; D012486:Salmonella typhimurium / Q000276:immunology*; D044967:Serum / Q000276:immunology*
chemical_list: D007136:Immunoglobulins; C042866:antilipopolysaccharide antibodies
references.citation: FEMS Immunol Med Microbiol. 2002 Jul 12;33(3):165-71
references.pmid: 12110478
references.citation: N Engl J Med. 2011 Nov 17;365(20):1863-75
references.pmid: 22007715
references.citation: Ann Intern Med. 1985 Feb;102(2):186-8
references.pmid: 3881072
references.citation: Lancet Infect Dis. 2010 Jun;10(6):417-32
references.pmid: 20510282
references.citation: J Med Microbiol. 2006 May;55(Pt 5):585-591
references.pmid: 16585646
references.citation: Expert Rev Anti Infect Ther. 2013 May;11(5):443-6
references.pmid: 23627848
references.citation: J Exp Med. 1965 Aug 1;122:385-402
references.pmid: 14316950
references.citation: Scand J Infect Dis. 1990;22(4):451-5
references.pmid: 2218408
references.citation: Microb Pathog. 2013 Oct;63:19-23
references.pmid: 23756206
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9803-8
references.pmid: 19487686
references.citation: J Clin Invest. 2008 Apr;118(4):1553-62
references.pmid: 18357343
references.citation: Pediatr Infect Dis J. 2009 Feb;28(2):108-13
references.pmid: 19131902
references.citation: Clin Vaccine Immunol. 2013 Oct;20(10):1491-8
references.pmid: 23803904
references.citation: Genome Res. 2009 Dec;19(12):2279-87
references.pmid: 19901036
references.citation: Clin Infect Dis. 2001 Jan 15;32(2):263-9
references.pmid: 11170916
references.citation: Science. 2010 Apr 23;328(5977):508-12
references.pmid: 20413503
references.citation: Infect Immun. 2011 Oct;79(10):4240-9
references.pmid: 21807909
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3070-5
references.pmid: 20133627
references.citation: AIDS. 2002 Aug 16;16(12):1633-41
references.pmid: 12172085
references.citation: Lancet. 1983 Mar 19;1(8325):642
references.pmid: 6131313
references.citation: J Immunol. 2007 May 15;178(10):6200-7
references.pmid: 17475847
references.citation: N Engl J Med. 2008 Feb 28;358(9):888-99
references.pmid: 18305266
references.citation: Nat Genet. 2012 Nov;44(11):1215-21
references.pmid: 23023330
references.citation: Lancet. 1990 Sep 1;336(8714):545-9
references.pmid: 1975046
references.citation: Clin Vaccine Immunol. 2014 May;21(5):712-21
references.pmid: 24623629
references.citation: Lancet. 2012 Jun 30;379(9835):2489-2499
references.pmid: 22587967
references.citation: Ann Trop Paediatr. 2009 Mar;29(1):13-22
references.pmid: 19222929
references.citation: J Infect Dis. 1987 Jun;155(6):1319-21
references.pmid: 3553352
references.citation: Proc Natl Acad Sci U S A. 1986 Jul;83(14):5189-93
references.pmid: 3523484
references.citation: BMC Infect Dis. 2006 Nov 07;6:160
references.pmid: 17090299
references.citation: PLoS One. 2013 May 31;8(5):e64680
references.pmid: 23741368